Targeted liver chemo tested to extend lives in Tough-to-Treat cancer
NCT ID NCT05024513
Summary
This study tested if adding a targeted chemotherapy directly into the liver's blood supply could help people with advanced bile duct cancer live longer. All participants received standard care to drain blocked bile ducts. Then, half also received the targeted chemotherapy, while the other half received only supportive care. The goal was to see if this approach could better control the tumor and extend survival for patients who are not eligible for surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIHILAR CHOLANGIOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Interventional Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education),Peking University Cancer Hospital and Institute
Beijing, China
Conditions
Explore the condition pages connected to this study.